Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menetrier-Caux, C.
Right arrow Articles by Blay, J.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menetrier-Caux, C.
Right arrow Articles by Blay, J.Y.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 92 No. 12 (December 15), 1998: pp. 4778-4791

Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor

C. Menetrier-Caux, G. Montmain, M.C. Dieu, C. Bain, M.C. Favrot, C. Caux, and J.Y. Blay

From Unité Cytokine et Cancer, Unité INSERM 453, Centre Léon Bérard, Lyon, France; and Schering Plough, Dardilly, France.

The escape of malignant cells from the immune response against the tumor may result from a defective differentiation or function of professional antigen-presenting cells (APC), ie, dendritic cells (DC). To test this hypothesis, the effect of human renal cell carcinoma cell lines (RCC) on the development of DC from CD34+ progenitors was investigated in vitro. RCC cell lines were found to release soluble factors that inhibit the differentiation of CD34+ cells into DC and trigger their commitment towards monocytic cells (CD14+CD64+CD1a-CD86-CD80-HLA-DRlow) with a potent phagocytic capacity but lacking APC function. RCC CM were found to act on the two distinct subpopulations emerging in the culture at day 6 ([CD14+CD1a-] and [CD14-CD1a+]) by inhibiting the differentiation into DC of [CD14+CD1a-] precursors and blocking the acquisition of APC function of the [CD14-CD1a+] derived DC. Interleukin-6 (IL-6) and macrophage colony-stimulating factor (M-CSF) were found to be responsible for this phenomenon: antibodies against IL-6 and M-CSF abrogated the inhibitory effects of RCC CM; and recombinant IL-6 and/or M-CSF inhibited the differentiation of DC similarly to RCC CM. The inhibition of DC differentiation by RCC CM was preceeded by an induction of M-CSF receptor (M-CSFR; CD115) and a loss of granulocyte-macrophage colony-stimulating factor receptor alpha (GM-CSFRalpha ; CD116) expression at the surface of CD34+ cells, two phenomenon reversed by anti-IL-6/IL-6R and anti-M-CSF antibodies, respectively. Finally, a panel of tumor cell lines producing IL-6 and M-CSF induced similar effects. Taken together, the results suggest that the inhibition of DC development could represent a frequent mechanism by which tumor cells will escape immune recognition.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. Hiasa, M. Abe, A. Nakano, A. Oda, H. Amou, S. Kido, K. Takeuchi, K. Kagawa, K. Yata, T. Hashimoto, et al.
GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-{alpha} converting enzyme (TACE)
Blood, November 12, 2009; 114(20): 4517 - 4526.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Shinriki, H. Jono, K. Ota, M. Ueda, M. Kudo, T. Ota, Y. Oike, M. Endo, M. Ibusuki, A. Hiraki, et al.
Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
Clin. Cancer Res., September 1, 2009; 15(17): 5426 - 5434.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Gobert, I. Treilleux, N. Bendriss-Vermare, T. Bachelot, S. Goddard-Leon, V. Arfi, C. Biota, A. C. Doffin, I. Durand, D. Olive, et al.
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Cancer Res., March 1, 2009; 69(5): 2000 - 2009.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Rate, J. W. Upham, A. Bosco, K. L. McKenna, and P. G. Holt
Airway Epithelial Cells Regulate the Functional Phenotype of Locally Differentiating Dendritic Cells: Implications for the Pathogenesis of Infectious and Allergic Airway Disease
J. Immunol., January 1, 2009; 182(1): 72 - 83.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. Quante and T. C. Wang
Inflammation and Stem Cells in Gastrointestinal Carcinogenesis
Physiology, December 1, 2008; 23(6): 350 - 359.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Cheng, C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al.
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
J. Exp. Med., September 29, 2008; 205(10): 2235 - 2249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Ahmadi, D. C. Emery, and D. J. Morgan
Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells In vivo
Cancer Res., September 15, 2008; 68(18): 7520 - 7529.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. van Cruijsen, A. A.M. van der Veldt, L. Vroling, D. Oosterhoff, H. J. Broxterman, R. J. Scheper, G. Giaccone, J. B.A.G. Haanen, A. J.M. van den Eertwegh, E. Boven, et al.
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Clin. Cancer Res., September 15, 2008; 14(18): 5884 - 5892.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. A. Hamilton, G. Whitty, P. Masendycz, N. J. Wilson, J. Jackson, D. De Nardo, and G. M. Scholz
The Critical Role of the Colony-Stimulating Factor-1 Receptor in the Differentiation of Myeloblastic Leukemia Cells
Mol. Cancer Res., March 1, 2008; 6(3): 458 - 467.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Nonaka, B. Y. Ma, R. Murai, N. Nakamura, M. Baba, N. Kawasaki, K. Hodohara, S. Asano, and T. Kawasaki
Glycosylation-Dependent Interactions of C-Type Lectin DC-SIGN with Colorectal Tumor-Associated Lewis Glycans Impair the Function and Differentiation of Monocyte-Derived Dendritic Cells
J. Immunol., March 1, 2008; 180(5): 3347 - 3356.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P.-Y. Pan, G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Blood, January 1, 2008; 111(1): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Duluc, Y. Delneste, F. Tan, M.-P. Moles, L. Grimaud, J. Lenoir, L. Preisser, I. Anegon, L. Catala, N. Ifrah, et al.
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Blood, December 15, 2007; 110(13): 4319 - 4330.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. S. Lo, P. Gorak-Stolinska, V. Bachy, M. A. Ibrahim, D. M. Kemeny, and J. Maher
Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3'-kinase and delayed caspase activation
J. Leukoc. Biol., December 1, 2007; 82(6): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. K. Bunt, L. Yang, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg
Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression
Cancer Res., October 15, 2007; 67(20): 10019 - 10026.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed
Normalization of the Ovarian Cancer Microenvironment by SPARC
Mol. Cancer Res., October 1, 2007; 5(10): 1015 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Tonello and G. Poli
Tubal ectopic pregnancy: macrophages under the microscope
Hum. Reprod., October 1, 2007; 22(10): 2577 - 2584.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Bharadwaj, M. Li, R. Zhang, C. Chen, and Q. Yao
Elevated Interleukin-6 and G-CSF in Human Pancreatic Cancer Cell Conditioned Medium Suppress Dendritic Cell Differentiation and Activation
Cancer Res., June 1, 2007; 67(11): 5479 - 5488.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Nakano, Y. Okada, K. Saito, R. Tanikawa, N. Sawamukai, Y. Sasaguri, T. Kohro, Y. Wada, T. Kodama, and Y. Tanaka
Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis
Rheumatology, April 1, 2007; 46(4): 597 - 603.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
A. Jewett, C. Head, and N.A. Cacalano
Emerging Mechanisms of Immunosuppression in Oral Cancers
Journal of Dental Research, December 1, 2006; 85(12): 1061 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Hargadon, C. C. Brinkman, S. L. Sheasley-O'Neill, L. A. Nichols, T. N. J. Bullock, and V. H. Engelhard
Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes
J. Immunol., November 1, 2006; 177(9): 6081 - 6090.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells
J. Immunol., August 15, 2006; 177(4): 2080 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Griffioen, J. H. Kessler, M. Borghi, R. A. van Soest, C. E. van der Minne, J. Nouta, S. H. van der Burg, J. P. Medema, P. I. Schrier, J.H. F. Falkenburg, et al.
Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell Therapy.
Clin. Cancer Res., May 15, 2006; 12(10): 3130 - 3136.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Appel, A. Bringmann, F. Grunebach, M. M. Weck, J. Bauer, and P. Brossart
Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs
Blood, April 15, 2006; 107(8): 3265 - 3270.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Gottfried, L. A. Kunz-Schughart, S. Ebner, W. Mueller-Klieser, S. Hoves, R. Andreesen, A. Mackensen, and M. Kreutz
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Blood, March 1, 2006; 107(5): 2013 - 2021.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. X. Heinz, B. Platzer, P. M. Reisner, A. Jorgl, S. Taschner, F. Gobel, and H. Strobl
Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment
Blood, February 15, 2006; 107(4): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Preynat-Seauve, P. Schuler, E. Contassot, F. Beermann, B. Huard, and L. E. French
Tumor-Infiltrating Dendritic Cells Are Potent Antigen-Presenting Cells Able to Activate T Cells and Mediate Tumor Rejection
J. Immunol., January 1, 2006; 176(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nefedova, S. Nagaraj, A. Rosenbauer, C. Muro-Cacho, S. M. Sebti, and D. I. Gabrilovich
Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway
Cancer Res., October 15, 2005; 65(20): 9525 - 9535.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ostrowski, M. Vermeulen, O. Zabal, J. R. Geffner, A. M. Sadir, and O. J. Lopez
Impairment of Thymus-Dependent Responses by Murine Dendritic Cells Infected with Foot-and-Mouth Disease Virus
J. Immunol., September 15, 2005; 175(6): 3971 - 3979.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. P.J.M. van Gisbergen, C. A. Aarnoudse, G. A. Meijer, T. B.H. Geijtenbeek, and Y. van Kooyk
Dendritic Cells Recognize Tumor-Specific Glycosylation of Carcinoembryonic Antigen on Colorectal Cancer Cells through Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin
Cancer Res., July 1, 2005; 65(13): 5935 - 5944.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Li, Y.-J. Kim, and H. E. Broxmeyer
Macrophage Colony-Stimulating Factor Drives Cord Blood Monocyte Differentiation into IL-10highIL-12absent Dendritic Cells with Tolerogenic Potential
J. Immunol., April 15, 2005; 174(8): 4706 - 4717.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Bakri, S. Sarrazin, U. P. Mayer, S. Tillmanns, C. Nerlov, A. Boned, and M. H. Sieweke
Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate
Blood, April 1, 2005; 105(7): 2707 - 2716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Alberti, T. Bachelot, A. Duc, C. Biota, and J. Y. Blay
A Spliced Isoform of Interleukin 6 mRNA Produced by Renal Cell Carcinoma Encodes for an Interleukin 6 Inhibitor
Cancer Res., January 1, 2005; 65(1): 2 - 5.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Platzer, A. Jorgl, S. Taschner, B. Hocher, and H. Strobl
RelB regulates human dendritic cell subset development by promoting monocyte intermediates
Blood, December 1, 2004; 104(12): 3655 - 3663.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Bonnotte, M. Crittenden, N. Larmonier, M. Gough, and R. G. Vile
MIP-3{alpha} Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity
J. Immunol., October 15, 2004; 173(8): 4929 - 4935.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. Um, C. Mulhall, A. Alisa, A. R. Ives, J. Karani, R. Williams, A. Bertoletti, and S. Behboudi
{alpha}-Fetoprotein Impairs APC Function and Induces Their Apoptosis
J. Immunol., August 1, 2004; 173(3): 1772 - 1778.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
E. G. Engleman, J. Brody, and L. Soares
Using Signaling Pathways to Overcome Immune Tolerance to Tumors
Sci. Signal., July 13, 2004; 2004(241): pe28 - pe28.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Negrier, D. Perol, C. Menetrier-Caux, B. Escudier, M. Pallardy, A. Ravaud, J.-Y. Douillard, C. Chevreau, C. Lasset, and J.-Y. Blay
Interleukin-6, Interleukin-10, and Vascular Endothelial Growth Factor in Metastatic Renal Cell Carcinoma: Prognostic Value of Interleukin-6--From the Groupe Francais d'Immunotherapie
J. Clin. Oncol., June 15, 2004; 22(12): 2371 - 2378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Monti, B. E. Leone, A. Zerbi, G. Balzano, S. Cainarca, V. Sordi, M. Pontillo, A. Mercalli, V. Di Carlo, P. Allavena, et al.
Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell
J. Immunol., June 15, 2004; 172(12): 7341 - 7349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. I. Bleier, V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo
Increased and Long-Term Generation of Dendritic Cells with Reduced Function from IL-6-Deficient Bone Marrow
J. Immunol., June 15, 2004; 172(12): 7408 - 7416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. H. Slager, C. E. van der Minne, M. Kruse, D. D. Krueger, M. Griffioen, and S. Osanto
Identification of Multiple HLA-DR-Restricted Epitopes of the Tumor-Associated Antigen CAMEL by CD4+ Th1/Th2 Lymphocytes
J. Immunol., April 15, 2004; 172(8): 5095 - 5102.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
D. Rubin
Integrative Tumor Board: Metastatic Renal Cell Carcinoma
Integr Cancer Ther, March 1, 2004; 3(1): 34 - 41.
[PDF]


Home page
Cancer Res.Home page
Q. Li, P.-Y. Pan, P. Gu, D. Xu, and S.-H. Chen
Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Cancer Res., February 1, 2004; 64(3): 1130 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Nefedova, M. Huang, S. Kusmartsev, R. Bhattacharya, P. Cheng, R. Salup, R. Jove, and D. Gabrilovich
Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer
J. Immunol., January 1, 2004; 172(1): 464 - 474.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Hartmann, B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann
Identification and Functional Analysis of Tumor-Infiltrating Plasmacytoid Dendritic Cells in Head and Neck Cancer
Cancer Res., October 1, 2003; 63(19): 6478 - 6487.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Hayashi, T. Hideshima, M. Akiyama, N. Raje, P. Richardson, D. Chauhan, and K. C. Anderson
Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes
Blood, August 15, 2003; 102(4): 1435 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Orsini, A. Guarini, S. Chiaretti, F. R. Mauro, and R. Foa
The Circulating Dendritic Cell Compartment in Patients with Chronic Lymphocytic Leukemia Is Severely Defective and Unable to Stimulate an Effective T-Cell Response
Cancer Res., August 1, 2003; 63(15): 4497 - 4506.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Kusmartsev and D. I. Gabrilovich
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
J. Leukoc. Biol., August 1, 2003; 74(2): 186 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. De, K. Laudanski, and C. L. Miller-Graziano
Failure of Monocytes of Trauma Patients to Convert to Immature Dendritic Cells is Related to Preferential Macrophage-Colony-Stimulating Factor-Driven Macrophage Differentiation
J. Immunol., June 15, 2003; 170(12): 6355 - 6362.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. M. Woltman and C. van Kooten
Functional modulation of dendritic cells to suppress adaptive immune responses
J. Leukoc. Biol., April 1, 2003; 73(4): 428 - 441.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Peguet-Navarro, M. Sportouch, I. Popa, O. Berthier, D. Schmitt, and J. Portoukalian
Gangliosides from Human Melanoma Tumors Impair Dendritic Cell Differentiation from Monocytes and Induce Their Apoptosis
J. Immunol., April 1, 2003; 170(7): 3488 - 3494.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Sharma, M. Stolina, S.-C. Yang, F. Baratelli, J. F. Lin, K. Atianzar, J. Luo, L. Zhu, Y. Lin, M. Huang, et al.
Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function
Clin. Cancer Res., March 1, 2003; 9(3): 961 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. H. Slager, M. Borghi, C. E. van der Minne, C. A. Aarnoudse, M. J. E. Havenga, P. I. Schrier, S. Osanto, and M. Griffioen
CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame
J. Immunol., February 1, 2003; 170(3): 1490 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-i. Fujii, K. Shimizu, F. Koji, and F. Kawano
Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential
J. Leukoc. Biol., January 1, 2003; 73(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Delneste, P. Charbonnier, N. Herbault, G. Magistrelli, G. Caron, J.-Y. Bonnefoy, and P. Jeannin
Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages
Blood, January 1, 2003; 101(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Ryan, A. J. Marshall, D. Magaletti, H. Floyd, K. E. Draves, N. E. Olson, and E. A. Clark
Dendritic Cell-Associated Lectin-1: A Novel Dendritic Cell-Associated, C-Type Lectin-Like Molecule Enhances T Cell Secretion of IL-4
J. Immunol., November 15, 2002; 169(10): 5638 - 5648.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. I. Gabrilovich, P. Cheng, Y. Fan, B. Yu, E. Nikitina, A. Sirotkin, M. Shurin, T. Oyama, Y. Adachi, S. Nadaf, et al.
H1{degrees} histone and differentiation of dendritic cells. A molecular target for tumor-derived factors
J. Leukoc. Biol., August 1, 2002; 72(2): 285 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. J. Bontkes, T. D. de Gruijl, G. J. Schuurhuis, R. J. Scheper, C. J. L. M. Meijer, and E. Hooijberg
Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome
J. Leukoc. Biol., August 1, 2002; 72(2): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Mashino, N. Sadanaga, F. Tanaka, M. Ohta, H. Yamaguchi, and M. Mori
Effective Strategy of Dendritic Cell-based Immunotherapy for Advanced Tumor-bearing Hosts: the Critical Role of Th1-dominant Immunity
Mol. Cancer Ther., August 1, 2002; 1(10): 785 - 794.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Ratta, F. Fagnoni, A. Curti, R. Vescovini, P. Sansoni, B. Oliviero, M. Fogli, E. Ferri, G. R. Della Cuna, S. Tura, et al.
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Blood, June 17, 2002; 100(1): 230 - 237.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Padovan, L. Terracciano, U. Certa, B. Jacobs, A. Reschner, M. Bolli, G. C. Spagnoli, E. C. Borden, and M. Heberer
Interferon Stimulated Gene 15 Constitutively Produced by Melanoma Cells Induces E-Cadherin Expression on Human Dendritic Cells
Cancer Res., June 1, 2002; 62(12): 3453 - 3458.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Acres, P. Beverley, and S. Scholl
Tumor Immunology and the Battle of Waterloo
Mol. Cancer Ther., June 1, 2002; 1(8): 651 - 655.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Sombroek, A. G. M. Stam, A. J. Masterson, S. M. Lougheed, M. J. A. G. Schakel, C. J. L. M. Meijer, H. M. Pinedo, A. J. M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation
J. Immunol., May 1, 2002; 168(9): 4333 - 4343.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Merad, T. Sugie, E. G. Engleman, and L. Fong
In vivo manipulation of dendritic cells to induce therapeutic immunity
Blood, March 1, 2002; 99(5): 1676 - 1682.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Fong, D. Brockstedt, C. Benike, J. K. Breen, G. Strang, C. L. Ruegg, and E. G. Engleman
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
J. Immunol., December 15, 2001; 167(12): 7150 - 7156.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. G. S. Buggins, D. Milojkovic, M. J. Arno, N. C. Lea, G. J. Mufti, N. S. B. Thomas, and W. J. R. Hirst
Microenvironment Produced by Acute Myeloid Leukemia Cells Prevents T Cell Activation and Proliferation by Inhibition of NF-{kappa}B, c-Myc, and pRb Pathways
J. Immunol., November 15, 2001; 167(10): 6021 - 6030.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Kurth, K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser
Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney-Expressed Chemokine (Brak) in Macrophage Development
J. Exp. Med., September 17, 2001; 194(6): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Novak, T. Bieber, and N. Katoh
Engagement of Fc{{epsilon}}RI on Human Monocytes Induces the Production of IL-10 and Prevents Their Differentiation in Dendritic Cells
J. Immunol., July 15, 2001; 167(2): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson
Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL
J. Immunol., May 1, 2001; 166(9): 5557 - 5566.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Curti, M. Ratta, S. Corinti, G. Girolomoni, F. Ricci, P. Tazzari, M. Siena, A. Grande, M. Fogli, S. Tura, et al.
Interleukin-11 induces Th2 polarization of human CD4+ T cells
Blood, May 1, 2001; 97(9): 2758 - 2763.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Menetrier-Caux, M. C. Thomachot, L. Alberti, G. Montmain, and J. Y. Blay
IL-4 Prevents the Blockade of Dendritic Cell Differentiation Induced by Tumor Cells
Cancer Res., April 1, 2001; 61(7): 3096 - 3104.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
C Baron, G Raposo, S. Scholl, H Bausinger, D Tenza, A Bohbot, P Pouillart, B Goud, D Hanau, and J Salamero
Modulation of MHC class II transport and lysosome distribution by macrophage-colony stimulating factor in human dendritic cells derived from monocytes
J. Cell Sci., January 3, 2001; 114(5): 999 - 1010.
[Abstract] [PDF]


Home page
J. Immunol.Home page
B. Almand, J. I. Clark, E. Nikitina, J. van Beynen, N. R. English, S. C. Knight, D. P. Carbone, and D. I. Gabrilovich
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
J. Immunol., January 1, 2001; 166(1): 678 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-C. J. Chang, A. Wright, and J. Punnonen
Monocyte-Derived CD1a+ and CD1a- Dendritic Cell Subsets Differ in Their Cytokine Production Profiles, Susceptibilities to Transfection, and Capacities to Direct Th Cell Differentiation
J. Immunol., October 1, 2000; 165(7): 3584 - 3591.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
J. Immunol., August 15, 2000; 165(4): 1992 - 2000.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Almand, J. R. Resser, B. Lindman, S. Nadaf, J. I. Clark, E. D. Kwon, D. P. Carbone, and D. I. Gabrilovich
Clinical Significance of Defective Dendritic Cell Differentiation in Cancer
Clin. Cancer Res., May 1, 2000; 6(5): 1755 - 1766.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D. Roth, B. J. Gitlitz, S. M. Kiertscher, A. N. Park, M. Mendenhall, N. Moldawer, and R. A. Figlin
Granulocyte Macrophage Colony-stimulating Factor and Interleukin 4 Enhance the Number and Antigen-presenting Activity of Circulating CD14+ and CD83+ Cells in Cancer Patients
Cancer Res., April 1, 2000; 60(7): 1934 - 1941.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. M. Kiertscher, J. Luo, S. M. Dubinett, and M. D. Roth
Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells
J. Immunol., February 1, 2000; 164(3): 1269 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. P. Sester, S. J. Beasley, M. J. Sweet, L. F. Fowles, S. L. Cronau, K. J. Stacey, and D. A. Hume
Bacterial/CpG DNA Down-Modulates Colony Stimulating Factor-1 Receptor Surface Expression on Murine Bone Marrow-Derived Macrophages with Concomitant Growth Arrest and Factor-Independent Survival
J. Immunol., December 15, 1999; 163(12): 6541 - 6550.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Bell, P. Chomarat, D. Broyles, G. Netto, G. M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K. A. Palucka, and J. Banchereau
In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas
J. Exp. Med., November 15, 1999; 190(10): 1417 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. I. Gabrilovich, T. Ishida, S. Nadaf, J. E. Ohm, and D. P. Carbone
Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function
Clin. Cancer Res., October 1, 1999; 5(10): 2963 - 2970.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Corinti, D. Medaglini, A. Cavani, M. Rescigno, G. Pozzi, P. Ricciardi-Castagnoli, and G. Girolomoni
Human Dendritic Cells Very Efficiently Present a Heterologous Antigen Expressed on the Surface of Recombinant Gram-Positive Bacteria to CD4+ T Lymphocytes
J. Immunol., September 15, 1999; 163(6): 3029 - 3036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Ohm, M. R. Shurin, C. Esche, M. T. Lotze, D. P. Carbone, and D. I. Gabrilovich
Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo
J. Immunol., September 15, 1999; 163(6): 3260 - 3268.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020